J. M. Hoolachan Et Al. , "A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models," Human Molecular Genetics , vol.33, no.5, pp.400-425, 2024
Hoolachan, J. M. Et Al. 2024. A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models. Human Molecular Genetics , vol.33, no.5 , 400-425.
Hoolachan, J. M., McCallion, E., Sutton, E. R., Çetin, Ö., Pacheco-Torres, P., Dimitriadi, M., ... SARI, S.(2024). A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models. Human Molecular Genetics , vol.33, no.5, 400-425.
Hoolachan, Joseph Et Al. "A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models," Human Molecular Genetics , vol.33, no.5, 400-425, 2024
Hoolachan, Joseph M. Et Al. "A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models." Human Molecular Genetics , vol.33, no.5, pp.400-425, 2024
Hoolachan, J. M. Et Al. (2024) . "A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models." Human Molecular Genetics , vol.33, no.5, pp.400-425.
@article{article, author={Joseph M. Hoolachan Et Al. }, title={A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models}, journal={Human Molecular Genetics}, year=2024, pages={400-425} }